These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
281 related items for PubMed ID: 9810218
21. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. Karakiewicz PI, Shariat SF, Palapattu GS, Gilad AE, Lotan Y, Rogers CG, Vazina A, Gupta A, Bastian PJ, Perrotte P, Sagalowsky AI, Schoenberg M, Lerner SP. J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631 [Abstract] [Full Text] [Related]
22. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. Lotan Y, Gupta A, Shariat SF, Palapattu GS, Vazina A, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Perotte P, Schoenberg MP, Lerner SP, Sagalowsky AI. J Clin Oncol; 2005 Sep 20; 23(27):6533-9. PubMed ID: 16116151 [Abstract] [Full Text] [Related]
23. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M, Herr HW. J Urol; 2007 Dec 20; 178(6):2308-12; discussion 2313. PubMed ID: 17936804 [Abstract] [Full Text] [Related]
24. Transitional cell carcinoma of the bladder in young adults: presentation, natural history and outcome. Yossepowitch O, Dalbagni G. J Urol; 2002 Jul 20; 168(1):61-6. PubMed ID: 12050493 [Abstract] [Full Text] [Related]
25. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder. Rogers CG, Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Lotan Y, Gupta A, Vazina A, Gilad A, Sagalowsky AI, Lerner SP, Schoenberg MP. J Urol; 2006 Jun 20; 175(6):2048-53; discussion 2053. PubMed ID: 16697800 [Abstract] [Full Text] [Related]
26. Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients. Kamat AM, Dinney CP, Gee JR, Grossman HB, Siefker-Radtke AO, Tamboli P, Detry MA, Robinson TL, Pisters LL. Cancer; 2007 Jul 01; 110(1):62-7. PubMed ID: 17542024 [Abstract] [Full Text] [Related]
27. Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma. Ficarra V, Dalpiaz O, Alrabi N, Novara G, Galfano A, Artibani W. BJU Int; 2005 Apr 01; 95(6):786-90. PubMed ID: 15794783 [Abstract] [Full Text] [Related]
28. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer. Stein JP, Penson DF, Lee C, Cai J, Miranda G, Skinner DG. J Urol; 2009 May 01; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213 [Abstract] [Full Text] [Related]
29. [Radical cystectomy for superficial tumors in the BCG era]. Huguet Pérez J, Palou J, Millán Rodríguez F, Villavicencio Mavrich H, Rodríguez JV. Arch Esp Urol; 2002 May 01; 55(1):50-6. PubMed ID: 11957752 [Abstract] [Full Text] [Related]
30. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. Dutta SC, Smith JA, Shappell SB, Coffey CS, Chang SS, Cookson MS. J Urol; 2001 Aug 01; 166(2):490-3. PubMed ID: 11458053 [Abstract] [Full Text] [Related]
31. Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection. Holzbeierlein JM, Lopez-Corona E, Bochner BH, Herr HW, Donat SM, Russo P, Dalbagni G, Sogani PC. J Urol; 2004 Sep 01; 172(3):878-81. PubMed ID: 15310988 [Abstract] [Full Text] [Related]
32. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens. Kunju LP, You L, Zhang Y, Daignault S, Montie JE, Lee CT. J Urol; 2008 Nov 01; 180(5):1928-32; discussion 1932. PubMed ID: 18801529 [Abstract] [Full Text] [Related]
33. Treatment delay and prognosis in invasive bladder cancer. Liedberg F, Anderson H, Månsson W. J Urol; 2005 Nov 01; 174(5):1777-81; discussion 1781. PubMed ID: 16217282 [Abstract] [Full Text] [Related]
34. Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer. Isbarn H, Karakiewicz PI, Shariat SF, Capitanio U, Palapattu GS, Sagalowsky AI, Lotan Y, Schoenberg MP, Amiel GE, Lerner SP, Sonpavde G. J Urol; 2009 Aug 01; 182(2):459-65; discussion 465. PubMed ID: 19524971 [Abstract] [Full Text] [Related]
35. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Shariat SF, Palapattu GS, Karakiewicz PI, Rogers CG, Vazina A, Bastian PJ, Schoenberg MP, Lerner SP, Sagalowsky AI, Lotan Y. Eur Urol; 2007 Jan 01; 51(1):137-49; discussion 149-51. PubMed ID: 16793197 [Abstract] [Full Text] [Related]
36. The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy. Lambert EH, Pierorazio PM, Olsson CA, Benson MC, McKiernan JM, Poon S. BJU Int; 2007 Jul 01; 100(1):33-6. PubMed ID: 17552951 [Abstract] [Full Text] [Related]
37. Invasive T1 bladder cancer: indications and rationale for radical cystectomy. Stein JP, Penson DF. BJU Int; 2008 Aug 01; 102(3):270-5. PubMed ID: 18494831 [Abstract] [Full Text] [Related]
38. [Prognostic value of lymphatic metastasis in bladder cancer]. Martínez-Piñeiro L, Madrid J, Julve E, García Cardoso JV, Ortega L, de la Peña J, Martínez-Piñeiro JA. Arch Esp Urol; 1997 May 01; 50(4):365-71. PubMed ID: 9313045 [Abstract] [Full Text] [Related]
39. Prognostic significance of vascular invasion in patients with bladder cancer who underwent radical cystectomy. Harada K, Sakai I, Hara I, Eto H, Miyake H. Int J Urol; 2005 Mar 01; 12(3):250-5. PubMed ID: 15828951 [Abstract] [Full Text] [Related]